DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVAX (Q2019359): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item: The budget was changed) |
||||||
Property / budget | |||||||
761,887.32 Euro
| |||||||
Property / budget: 761,887.32 Euro / rank | |||||||
Normal rank | |||||||
Property / EU contribution | |||||||
0.0 Euro
| |||||||
Property / EU contribution: 0.0 Euro / rank | |||||||
Normal rank | |||||||
Property / co-financing rate | |||||||
0.0 percent
| |||||||
Property / co-financing rate: 0.0 percent / rank | |||||||
Normal rank |
Revision as of 22:31, 9 February 2022
Project Q2019359 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVAX |
Project Q2019359 in Italy |
Statements
0.0 Euro
0 references
761,887.32 Euro
0 references
0.0 percent
0 references
1 November 2016
0 references
31 December 2018
0 references
GENOMIX4LIFE SRL
0 references
Q277381 (Deleted Item)
0 references
BIOTECNOLOGIE (Italian)
0 references
BIOTECHNOLOGY (English)
0 references
BARONISSI
0 references
Identifiers
B18I17000200008
0 references